Aarvik Therapeutics Announces Validation of Novel Tetravalent Antibody Platform
HAYWARD, Calif.–(BUSINESS WIRE)–#antibodies—Aarvik Therapeutics announced the recent publication by Sachdev Sidhu, Ph.D., Co-founder of Aarvik Therapeutics, and his colleagues of a study validating the novel tetravalent antibody platform that forms a core component of innovation at Aarvik. This study by Miersch et al. uses modular design principles to combine neutralizing antibodies against two independent epitopes … [Read more…]
